A vs BBIO · P/E 29, rev $1.88B vs rev $221.9M
Agilent Technologies Inc (A) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
A currently screens at market cap $33.70B and trailing P/E 29.2. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the A and BBIO stock pages for the full models.
Not investment advice.